No use cases configured yet.
A multi-agent layer over the simulation core. IRIS reads your protocol, proposes scenarios, runs them in parallel, and returns the trial design most likely to succeed — with the evidence trail attached.
Read the IRIS paper 500+ validated modeling frameworks.
Calibrated against your data.
Causal by design. Regulatory-grade evidence.
Every what-if scenario, simulated. Every design, stress tested. Before the first patient
Feasibility, forecasting, execution - all in the same environment.
Mechanistic models, AI, digital twins, synthetic data, and operations forecasting — integrated in a single environment.
Access to cutting-edge, validated research, and technologies through a broad global network of partners
FDA, EMA and industry — compliance and contributors to the development of emerging good practice frameworks
Including 'Toward Good Simulation Practice'
(Co-authored with the U.S. FDA)
De-risk every stage from preclinical to post-approval
We are very delighted to initiate this collaboration with InSilicoTrials and have the opportunity to optimize and accelerate our next clinical steps — integrating their industry-leading AI and computational modeling solutions into the development plan of our promising disease-modifying drug will allow us to address the pressing challenges faced by individuals suffering from neurological disorders.